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license (http://creativecommons.org/Abstract Objective: In cardiac magnetic resonance imaging (CMR), incidental pathological
findings are frequently found outside the investigated cardiovascular system. Some of these
findings might have clinical implications. The aim of this study was to determine the preva-
lence of incidental extracardiac findings (ECF) in CMR and their clinical significance.
Methods: A total of 4165 CMR reports from 2009-2012 were retrospectively reviewed for ECF. Two
hundred-twenty reports with ECF were found. For each case, we obtained information on sex, age
of the patient, reported ECF and radiologist recommendation. Follow-up data were analyzed by re-
viewing available electronic medical records. ECF was considered clinically significant if there was
an associated diagnosis, additional treatment or further investigations in the clinical follow-up data.
Results: In total, 356 ECF were recorded in 220 (5.3%) CMR reports. Sixty (23.7%) of the 253 ECF
with follow-up data available were clinically significant. The most prevalent ECF were pleural
effusions (nZ 54), kidney cysts (nZ 54), diffuse lung parenchyma changes (nZ 33) and liver
cysts (nZ 29). Adrenal pathology (nZ 3, 100% significant), renal masses (nZ 3, 100%) and pul-
monary masses (nZ 5, 62.5%) were the most clinically significant ECF. Although prevalence of
these ECF was low, they were significant particularly frequently. When radiologist recommenda-
tions for further investigation were present in the report, the frequency of clinically significant
ECF was higher compared to reports with no further investigation recommended (p< 0.001).
Conclusion: In this study, ECF in CMR were reported not very commonly (5.3%). A substantial
part of ECF was clinically significant, changing patient diagnosis or management, with an overall
prevalence of 1.3%.
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Cardiac and cardiovascular magnetic resonance imaging
(CMR) is increasingly used to visualize and evaluate the
cardiovascular system.1e4 Wide spatial coverage of this
imaging technique, capturing anatomical regions of the
thoracic and upper abdominal cavity, may lead to inci-
dental pathological findings outside the investigated car-
diovascular system, e.g., in the adjacent organs e lungs,
kidneys, and so on.
Incidental findings are observed in various imaging mo-
dalities. They are particularly relevant for high resolution
cross-sectional imaging, e.g., computed or magnetic reso-
nance tomography, with their potential clinical benefits
and challenges being debated.5e8 Reported prevalence of
extracardiac findings (ECF) in cardiac MRI range from 7.6%9
to 81%.10 Some of these ECF might have clinical implications
including result in a new diagnosis, lead to further in-
vestigations or require early treatment. A few studies have
sought to evaluate the prevalence of ECF in CMR;9e14
however, information about the clinical significance is
scarce. Only a few studies analyzed the clinical follow-up of
the incidental findings, with a limited study population and
different evaluation methods.9,11,14
This study aimed to determine the prevalence of ECF in
a large set of clinically indicated CMR and their clinical
significance by reviewing how they reflect the subsequent
diagnosis, further investigations and treatment plan of the
patient.
2. Methods
The study retrospectively analyzed reports of clinically
indicated CMR performed at a single academic hospital
from January 1, 2009, to October 2, 2012. In total, 4165
clinical CMR reports were reviewed. This study was per-
formed in accordance with the regulations of the local
ethics committee, approval Nr. 158200-13-576-178, 2013-
02-12.
CMRs were performed on a 1.5 T Siemens Avanto system
(Siemens Medical Solutions, Erlangen, Germany) following a
standard protocol (including spin echo e black blood cor-
onal and axial sequences, gradient ECHO sequences, dy-
namic images: short axis, four chamber and three chamber
views, myocardial perfusion sequence and delayed contrast
enhancement sequences). As a result of scanning both the
heart and the major vessels, CMR scans covered the
thoracic and abdominal cavities to the bifurcation of aorta.
All scans were analyzed by 2 general radiologists, 10 and 20
years after completion of training, respectively, and with 7
and 10 years of cardiovascular imaging experience.
From the 4165 reports analyzed, 220 CMR reports
included at least one ECF. Further data obtained from these
reports included sex, age, reported ECF and subjective
radiologist recommendations for additional follow-up or
different imaging modality investigations. Normal anatom-
ical variation was not considered as ECF. ECF was defined as
any pathological extracardiac finding in the CMR scan. Both
potentially malignant and generally benign ECF were
recorded, with no exclusion criteria regarding size, loca-
tion, and so on. ECF were then grouped into broadercategories according to their location and appearance
(focal/diffuse) (e.g., liver mass or diffuse liver disease).
Renal and hepatic cysts (i.e., focal lesions with signal in-
tensity of water) were considered separately from other
focal masses due to their benign character. Rare pathol-
ogies (e.g., spinal scoliosis, other spine deformities, and
hemangiomas) were grouped according to the organ or
system affected (e.g., spinal pathology).
To assess the clinical implications of ECF, follow-up data
were analyzed by reviewing the electronic medical records
database of the hospital. According to the follow-up data,
ECF (for which data were available) were classified as
clinically significant or insignificant. ECF were considered
clinically significant if in the follow-up data there was an
associated clinically relevant diagnosis, planned or
completed treatment or further investigation of the ECF.
Findings that were for some reason noted in the diagnosis
but did not require any clinical attention (e.g., simple renal
cyst) were considered insignificant.
2.1. Statistical analysis
Statistical analysis was performed with commercially
available software (SPSS Inc., version 18.0, Chicago, IL,
USA). Averages are presented with 1 standard deviation
(SD). Categorical variables are presented as frequencies
and percentages and compared using the chi-square test.
Continuous variables were compared using two tailed Stu-
dent’s t test. Associations were considered significant at P
value <0.05.3. Results
3.1. Prevalence
A total of 4165 unique CMR cases were reviewed. ECF were
reported in 220 (5.3%) cases, including 135 men and 85
women (age range from 9 to 86, mean age 44.7  20.8
years). In 97 (44.1%) of these cases, more than a single ECF
was reported. In total, 356 ECF (on average 1.62  0.85 for
a patient) were found. Examples of ECF are shown in
Figures 1, 2 and 3.
The most frequent ECF were pleural effusions, kidney
cysts, diffuse lung changes, and liver cysts (Table 1). ECF
were most frequently localized in lungs and pleura nZ 107
(30.1%), kidney and adrenal glands nZ 89 (25.0%) and the
liver nZ 57(16.0%). These localizations are consistent with
the spatial extent of CMR imaging in this study e thoracic
and upper abdominal cavities.
3.2. Clinical Significance
Clinical follow-up was available for 253 (71.1%) ECF, or for
151 patients in total. From these, 60 (23.7%) ECF proved to
be clinically significant. For 37 (24.5%) patients with follow-
up, at least one ECF was clinically significant, resulting in
an overall prevalence of 1.3%. The most common clinically
significant ECF were pleural effusion (nZ 11, 18% of all
significant ECF), diffuse lung changes (nZ 7, 12%), hepatic
mass (nZ 6, 10%), hepatic cyst (nZ 6, 10%) and pulmonary
Figure 1 An extracardiac finding in CMR e renal mass (black
arrow). T2_haste coronal view.
Figure 2 An extracardiac finding in CMR e hiatal hernia
(black arrow). GRE sagittal view.
Table 1 Prevalence of extracardiac findings in CMR
(nZ 356).
ECF Total, N % of all ECF
Pleural effusion 54 15.2
Renal cyst 54 15.2
Diffuse lung changes 33 9.3
Hepatic cyst 29 8.1
Accessory renal artery 21 5.9
Mediastinal lymphadenopathy 19 5.3
Hepatic mass 16 4.5
Pulmonary nodule 16 4.5
Gallstones 16 4.5
Figure 3 An extracardiac finding in CMR e bilateral pleural
effusion (black arrows). SSFP axial view.
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correlate with patient age (pZ 0.755) and did not vary
based on sex (pZ 0.626).
Relative clinical significance for a particular ECF was
defined as the proportion of the significant to total ECF(e.g., clinically significant pleural effusions to total pleural
effusions). Relatively, the most clinically significant ECF
were adrenal pathology (100%, i.e., all cases proved to be
clinically significant), renal mass (100%) and pulmonary
nodule (62.5%). Thus, although the prevalence of these ECF
was rather low, they were clinically significant particularly
frequently (see Table 2).
Radiologist recommendations for follow-up in-
vestigations (e.g., with a different modality or after a
certain period of time) in CMR reports were included for
101 (28.4%) ECF or 55 (25.0%) patients. From the latter,
follow-up data were available for 30 patients. ECF were
clinically significant more frequently if radiologist recom-
mendations were present (p< 0.001).
The number of ECF in a case correlated with their clin-
ical significance e the more ECF were found, the more
likely at least one of them was clinically significant
(pZ 0.014).
4. Discussion
This study aimed to determine the prevalence and clinical
significance of ECF in cardiovascular magnetic resonance. If
ECF resulted in a new diagnosis, modified treatment plan,
or was additionally investigated or imaged, it was deemed
Table 2 Relatively the most clinically significant extrac-
ardiac findings with follow-up.
ECF Clinically
significant, N
Total,
N
% of clinically
significant
Adrenal pathology 3 3 100
Renal mass 3 3 100
Pulmonary nodule 5 8 62.5
Hepatic mass 6 11 54.4
Hydronephrosis 2 4 50.0
Liver parenchyma
changes
2 4 50.0
Breast lesion 1 2 50.0
Ascites 2 5 40.0
Note. ECF that were found only once are omitted due to low
statistical reliability.
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CMR. This result is similar to the 7.6% prevalence found in a
smaller study by Chen et al.9 Approximately a quarter of
ECF were clinically significant in the follow-up e with an
overall prevalence in CMR of 1.3%.
The majority of incidental findings outside the investi-
gated system are clinically irrelevant or insignificant e
anatomical variations or benign minor changes, such as
simple cysts. However, they might also reveal clinically
significant pathologies in early stages. Early treatment of
such incidental pathologies (e.g., gall stones, early stage
kidney or lung tumor) might prevent their progression,
complications and eventually lead to better outcomes. On
the other hand, further investigation of an incidental
benign finding might be redundant and survival might not
be improved.15 Therefore, it is important to discriminate
between clinically significant and insignificant ECF and to
decide which should be treated and which could be left
alone.
A few studies have investigated this topic using different
designs and thus, making it difficult to compare their re-
sults. To determine the prevalence of ECF, it is possible to
conduct CMR on a random group of volunteers or to analyze
CMR cases already conducted for clinical indications.
Furthermore, clinical CMR can be specifically reviewed for
the second time in search of ECF or ECF can be tracked in
the original reports. All study designs provide different in-
sights into the topic, but they also render studies difficult
to compare.
The prevalence of ECF is the largest if they are specif-
ically sought for. McKenna et al found an 81% prevalence of
ECF in CMR in a group of volunteers,10 while Khosa et al
found 43% ECF prevalence with a second revision of clini-
cally indicated CMR.11 Analyzing the original clinical CMR
reports, Chan et al found a smaller prevalence of ECF e
7.6%.9 This rate is similar to our result (5.3%), as the study
designs were quite similar.
The definition of clinically significant or important ECF
is another source of confusion. Some studies have
employed an a priori definition and deliberately grouped
ECF as minor and major,13 potentially significant,12 benign,
indeterminate or worrisome.11 The allocation was usually
based on known clinical correlations or expected need forfurther investigation. However, a priori allocation might
not be accurate, as the same finding might be benign in
one case and significant in another.
Atalay et al14 defined all ECF included in the impression
section of the original cardiac MRI report as important and
all ECF that resulted in a new diagnosis, intervention or
treatment as significant. We used the same definition for
the clinically significant ECF in this study. The prevalence of
important ECF in the Atalay et al study was 27% compared
to 5.3% in our study. The prevalence of significant ECF was
5% compared to 1.3%, respectively. However, the surveyed
population was considerably bigger in our study (4165
subjects compared to 240).
Chan et al9 called an ECF significant only if an inter-
vention or a change in the patient’s management ensued,
excluding ECF that changed diagnosis only and ECF that
were known previously. This narrow definition led to a small
prevalence of significant ECF e 0.4%. In our study, we did
not have information on whether ECF was previously
known. However, even when a finding is already known,
additional incidental imaging may be valuable as a follow-
up opportunity. Changes or persistence of the incidentally
found pathology may provide important information,
helping to decide not to treat a patient unnecessarily.
Different prevalences reported in the studies could have
a few explanations. Firstly, more ECF are found with the
dedicated second revision of CMR (Chan et al9). Radiologists
tend to register only some, but not all, minor changes or
variations in the original clinical setting. This is especially
the case for clinically insignificant ECF that are not ex-
pected to change the treatment plan of the patient. Sec-
ondly, the choice of the radiologist of which ECF to include
in the report is sometimes subjective. In the follow-up of
this study, it was noticed that nominally identical ECF (e.g.,
renal or liver cyst) were included in the diagnosis incon-
sistently. In other words, the same ECF could be considered
significant in one case and insignificant in another. This
might mean that the definition of a significant ECF should
be further elaborated. A valuable insight would also be to
learn whether ECF inclusion in the diagnosis depends on a
subjective choice of the doctor, patient’s previous medical
history, present status, comorbidities or other factors.
In this study, ECF were also rated according to their
relative clinical significance. This was performed to high-
light some relatively rare ECF that were clinically signifi-
cant always or very frequently. This could signal that they
are associated with more grave or urgent conditions, and a
special attention should be paid. For instance, such rela-
tively more significant ECF were adrenal pathology, renal
mass and pulmonary nodule. In contrast, ECF that consti-
tuted the major part of significant ECF but were relatively
less important (e.g., pleural effusion, 24% of cases signifi-
cant; diffuse lung changes, 29% of cases significant) were
associated with milder diagnoses or were signs of compli-
cations, such as pneumonia.
Despite a large sample of patients and follow-up data,
this study is subject to a few limitations. Due to the
retrospective design, follow-up data were not available for
all patients, and it was also not known whether ECF had
already been found before. Additionally, we did not
perform a separate dedicated reading of the actual CMR
scans and focused only on the data from an original clinical
260 A. Ulyte et al.setting. Thus, the actual prevalence of ECF (as compared to
the prevalence in original clinical setting) could be higher.
More ECF, especially insignificant and minor findings, might
be detected with a second reading.
In conclusion, although the incidental findings outside
the investigated system in cardiovascular magnetic reso-
nance are quite rare, a tangible part of them is clinically
significant and might change a patient’s diagnosis, lead to
further investigations, intervention or treatment and
therefore should not be dismissed.
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